Position in ABBV
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$889,547
+$231,640 QoQ
Shares Held
3,535
+16.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.89%
of 13F equity value
Holder Rank
#2,653
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BCS Wealth Management holds $7,700,051 across 8 Drug Manufacturers - General names. ABBV ranks #4 (11.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,962 | $2,353,281 | |
| 2 | MRK |
Merck & Co., Inc.
|
15,887 | $2,041,479 | |
| 3 | JNJ |
Johnson & Johnson
|
3,739 | $949,593 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
3,535 | $889,547 | |
| 5 | PFE |
Pfizer Inc
|
26,000 | $626,080 | |
| 6 | AMGN |
Amgen Inc
|
843 | $305,267 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,112 | $294,553 | |
| 8 | NVS |
Novartis AG
|
1,533 | $240,251 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $889,547 | 3,535 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $657,907 | 3,025 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $1,337,123 | 5,852 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $651,090 | 2,812 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,182,213 | 6,369 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $1,235,958 | 5,899 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $1,048,252 | 5,899 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $1,144,989 | 5,798 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $978,693 | 5,706 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $992,445 | 5,450 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $798,250 | 5,151 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $767,808 | 5,151 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $693,994 | 5,151 | Shares | Sole | 2023-07-19 | |
| 2022-12-31 | $819,524 | 5,071 | Shares | Sole | 2023-01-10 | |
| 2022-09-30 | $682,592 | 5,086 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $778,971 | 5,086 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $824,491 | 5,086 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $692,164 | 5,112 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $548,626 | 5,086 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $572,887 | 5,086 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $783,188 | 7,237 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $775,444 | 7,237 | Shares | Sole | 2021-01-21 | |
| 2020-09-30 | $633,888 | 7,237 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $723,095 | 7,365 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $510,549 | 6,701 | Shares | Sole | 2020-04-10 | |
| No filing history on record for this holder in this stock. | ||||||